BioCentury
ARTICLE | Clinical News

Meridia sibutramine regulatory update

August 22, 2005 7:00 AM UTC

FDA rejected a Public Citizen petition to ban weight-loss drug Meridia because the agency believed that the overall risk-benefit profile supports keeping the drug available to obese patients. Public C...